Literature DB >> 16176894

Families living with HIV.

M J Rotheram-Borus1, D Flannery, E Rice, P Lester.   

Abstract

Given the historical emergence of the AIDS epidemic first among gay men in the developed world, HIV interventions have primarily focused on individuals rather than families. Typically not part of traditional family structures, HIV-positive gay men in Europe and the US lived primarily in societies providing essential infrastructure for survival needs that highly value individual justice and freedom. Interventions were thus designed to focus on at-risk individuals with programmes that were age and gender segregated. As the epidemic has unfolded, the early focus on individuals has become inadequate: families live with HIV, not just individuals. Families' structure, economy, migration patterns, and developmental life cycles are affected by HIV, and these changes radiate throughout the community creating parallel stresses. Family-based, intergenerational models of detection, prevention and treatment services offer enhanced opportunities for effective interventions and suggest very different intervention settings and strategies. However, these models also require addressing the family's basic needs for survival and security in order to be successfully implemented and sustained over time. As HIV was an opportunity for marginalized persons in the developed world to 'turn their life around', the strengths of families in the developing world may be mobilized to contribute to the community's long-term health, survival and security needs.

Entities:  

Mesh:

Year:  2005        PMID: 16176894     DOI: 10.1080/09540120500101690

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  48 in total

1.  Structural Ecosystems Therapy for recovering HIV-positive women: child, mother, and parenting outcomes.

Authors:  Victoria B Mitrani; Brian E McCabe; Carleen Robinson; Nomi S Weiss-Laxer; Daniel J Feaster
Journal:  J Fam Psychol       Date:  2010-12

2.  The efficacy of Structural Ecosystems Therapy for HIV medication adherence with African American women.

Authors:  Daniel J Feaster; Ahnalee M Brincks; Victoria B Mitrani; Guillermo Prado; Seth J Schwartz; Jose Szapocznik
Journal:  J Fam Psychol       Date:  2010-02

Review 3.  Behavior change and health-related interventions for heterosexual risk reduction among drug users.

Authors:  Salaam Semaan; Don C Des Jarlais; Rob Malow
Journal:  Subst Use Misuse       Date:  2006       Impact factor: 2.164

4.  Predicting depression in mothers with and without HIV: the role of social support and family dynamics.

Authors:  Typhanye Penniman Dyer; Judith A Stein; Eric Rice; Mary Jane Rotheram-Borus
Journal:  AIDS Behav       Date:  2012-11

5.  Impacts of HIV/AIDS Stigma on Family Identity and Interactions in China.

Authors:  Li Li; Zunyou Wu; Sheng Wu; Manhong Jia; Eli Lieber; Yao Lu
Journal:  Fam Syst Health       Date:  2008-12       Impact factor: 1.950

6.  Benefits of family and social relationships for Thai parents living with HIV.

Authors:  Mary Jane Rotheram-Borus; Judith A Stein; Chuleeporn Jiraphongsa; Siwaporn Khumtong; Sung-Jae Lee; Li Li
Journal:  Prev Sci       Date:  2010-09

7.  Maternal HIV, substance use role modeling, and adolescent girls' alcohol use.

Authors:  Julie A Cederbaum; Erick G Guerrero; Anamika Barman-Adhikari; Carol A Vincent
Journal:  J Assoc Nurses AIDS Care       Date:  2014-11-20       Impact factor: 1.354

8.  Family wellness, not HIV prevention.

Authors:  Mary Jane Rotheram-Borus; Dallas Swendeman; Diane Flannery
Journal:  AIDS Behav       Date:  2009-01-16

9.  HIV/AIDS patients' medical and psychosocial needs in the era of HAART: a cross-sectional study among HIV/AIDS patients receiving HAART in Yunnan, China.

Authors:  Yi Wen; Yun Shi; Chengqin Jiang; Roger Detels; Di Wu
Journal:  AIDS Care       Date:  2012-10-15

10.  Visioning services for children affected by HIV and AIDS through a family lens.

Authors:  Linda Richter; Chris Beyrer; Susan Kippax; Shirin Heidari
Journal:  J Int AIDS Soc       Date:  2010-06-23       Impact factor: 5.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.